Hart Stephanie A, Gailani David, Bibb Lorin A, Zwerner Jeffrey P, Booth Garrett S, Jacobs Jeremy W
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, US.
Division of Pediatric Dermatology, Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, US.
Am J Clin Pathol. 2025 Jun 3;163(6):822-836. doi: 10.1093/ajcp/aqaf001.
Hemostatic abnormalities, including disseminated intravascular coagulation (DIC), are often cited as a common finding in patients following Loxosceles spider envenomation (ie, loxoscelism). The prevalence and severity of coagulopathy, however, particularly following L reclusa (ie, brown recluse) envenomation, is not well described. This study aimed to characterize coagulation laboratory parameters and coagulopathy in patients following L reclusa envenomation.
We evaluated the coagulation laboratory parameters (eg, prothrombin time, partial thromboplastin time, coagulation factor activity levels, lupus anticoagulant [LA] testing) of 2 patients seen at our institution following brown recluse spider envenomation. We also comprehensively reviewed the literature for all reported cases of brown recluse spider envenomation and assessed patient demographics, clinical presentations, coagulation laboratory parameters, and outcomes.
We identified 2 patients with loxoscelism (1 cutaneous only, 1 systemic with hemolysis) with prolonged partial thromboplastin times but with normal clotting factor levels following envenomation. Literature review identified 263 patients: 12 patients had at least 1 prolonged clotting time, 31 reported a platelet count below 150 × 109/L, and there was clinical concern for DIC in 12 cases. The odds of death were statistically significantly higher in patients with clinical concern for DIC than in cases without concern for DIC or coagulopathy (odds ratio, 82.9 [95% CI, 12.6-433.8]; P < .001).
Following brown recluse spider envenomation, hemostatic perturbations are infrequent and clinical coagulopathy is uncommon, but the odds of death following a brown recluse spider bite are statistically significantly greater if DIC develops, even when compared to individuals with hemolysis without DIC.
止血异常,包括弥散性血管内凝血(DIC),常被认为是洛氏蝎螯蛛(即褐蛛)蜇伤患者(即褐蛛中毒)的常见表现。然而,凝血病的发生率和严重程度,尤其是在被褐蛛(即棕色遁蛛)蜇伤后,尚无详细描述。本研究旨在描述褐蛛蜇伤患者的凝血实验室参数及凝血病情况。
我们评估了在我院就诊的2例棕色遁蛛蜇伤患者的凝血实验室参数(如凝血酶原时间、部分凝血活酶时间、凝血因子活性水平、狼疮抗凝物[LA]检测)。我们还全面回顾了所有已报道的棕色遁蛛蜇伤病例的文献,并评估了患者的人口统计学特征、临床表现、凝血实验室参数及预后。
我们确定了2例褐蛛中毒患者(1例仅为皮肤中毒,1例为伴有溶血的全身中毒),蜇伤后部分凝血活酶时间延长,但凝血因子水平正常。文献回顾确定了263例患者:12例患者至少有1次凝血时间延长,31例报告血小板计数低于150×10⁹/L,12例患者临床上怀疑有DIC。临床上怀疑有DIC的患者死亡几率在统计学上显著高于无DIC或凝血病疑虑的患者(优势比,82.9[95%CI,12.6 - 433.8];P < 0.001)。
棕色遁蛛蜇伤后,止血紊乱不常见,临床凝血病也不常见,但如果发生DIC,棕色遁蛛咬伤后的死亡几率在统计学上显著更高,即使与无DIC的溶血患者相比也是如此。